Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Denka in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $17.75.
Current Consensus is
N/A
The current consensus among 0 investment analysts is to n/a stock in Denka. This N/A consensus rating has held steady for over two years.
Denka Company Limited manufactures and sells organic and inorganic materials to electronic materials and pharmaceuticals in Japan and internationally. The company's Electronics & Innovative Products division provides conductive agents for lithium for lithium-ion batteries, thermal materials and substrates, functional ceramics, films, and tapes. Its Life Innovation division works to improve people's life in the fields of prevention, diagnosis, and treatment, including influenza vaccines; test reagents, such as rapid testing kits for COVID-19; and macromolecular hyaluronate preparations. The company's Elastomers & Infrastructure Solutions division include functional elastomers, cement and special cement additives, fertilizers, agricultural products. Its Polymer Solutions division consist of styrene-based resins, food packaging sheets, and synthetic fiber for wigs, as well as poval and other chemical products. The company was formerly known as Denki Kagaku Kogyo Kabushiki Kaisha and changed its name to Denka Company Limited in October 2015. Denka Company Limited was incorporated in 1915 and is headquartered in Tokyo, Japan.
Read More
